DrazCanna Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
DrazCanna has 9.61 million shares outstanding.
| Current Share Class | 9.61M |
| Shares Outstanding | 9.61M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.59, with a Debt / Equity ratio of 0.32.
| Current Ratio | 0.59 |
| Quick Ratio | 0.15 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.04 |
| Interest Coverage | -163.35 |
Financial Efficiency
Return on equity (ROE) is -690.64% and return on invested capital (ROIC) is -318.16%.
| Return on Equity (ROE) | -690.64% |
| Return on Assets (ROA) | -117.82% |
| Return on Invested Capital (ROIC) | -318.16% |
| Return on Capital Employed (ROCE) | -559.52% |
| Weighted Average Cost of Capital (WACC) | 9.52% |
| Revenue Per Employee | 41,786 |
| Profits Per Employee | -116,624 |
| Employee Count | 67 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.93% in the last 52 weeks. The beta is -8.42, so DrazCanna's price volatility has been lower than the market average.
| Beta (5Y) | -8.42 |
| 52-Week Price Change | -99.93% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 40.67 |
| Average Volume (20 Days) | 5,370 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, DrazCanna had revenue of 2.05 million and -5.71 million in losses. Loss per share was -0.70.
| Revenue | 2.05M |
| Gross Profit | -229,251 |
| Operating Income | -5.63M |
| Pretax Income | -5.71M |
| Net Income | -5.71M |
| EBITDA | -5.13M |
| EBIT | -5.63M |
| Loss Per Share | -0.70 |
Balance Sheet
The company has 59,360 in cash and 286,319 in debt, giving a net cash position of -226,959 or -0.02 per share.
| Cash & Cash Equivalents | 59,360 |
| Total Debt | 286,319 |
| Net Cash | -226,959 |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 884,970 |
| Book Value Per Share | -0.01 |
| Working Capital | -521,851 |
Cash Flow
In the last 12 months, operating cash flow was -6.60 million and capital expenditures -49,877, giving a free cash flow of -6.65 million.
| Operating Cash Flow | -6.60M |
| Capital Expenditures | -49,877 |
| Free Cash Flow | -6.65M |
| FCF Per Share | -0.69 |
Margins
Gross margin is -11.20%, with operating and profit margins of -275.19% and -279.10%.
| Gross Margin | -11.20% |
| Operating Margin | -275.19% |
| Pretax Margin | -279.10% |
| Profit Margin | -279.10% |
| EBITDA Margin | -250.46% |
| EBIT Margin | -275.19% |
| FCF Margin | n/a |
Dividends & Yields
DrazCanna does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -331.19% |
| Shareholder Yield | -331.19% |
| Earnings Yield | -57,145,740.00% |
| FCF Yield | -66,476,280.00% |
Stock Splits
The last stock split was on March 25, 2022. It was a reverse split with a ratio of 0.0416667.
| Last Split Date | Mar 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0416667 |
Scores
DrazCanna has an Altman Z-Score of -15.68. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.68 |
| Piotroski F-Score | n/a |